Skip to content

Appalachian Partnership to Reduce Disparities (Aim 2)

Harnessing the Power of Peer Navigation and mHealth to Reduce Health Disparities in Appalachia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04378439
Enrollment
141
Registered
2020-05-07
Start date
2022-04-01
Completion date
2026-05-01
Last updated
2026-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS, STI, HCV

Keywords

PrEP

Brief summary

By combining two strategies (i.e., peer navigation and mHealth) into a complete, culturally compatible, bilingual intervention to increase the use of needed HIV, STI, and HCV prevention and care services among racially/ethnically diverse GBMSM and transgender women in rural Appalachia. Study Investigators anticipate that participants in the intervention group, relative to counterparts in the delayed-intervention group, will demonstrate increased HIV, STI, and HCV testing.

Detailed description

This CBPR study will advance prevention science and practice through testing an innovative intervention to promote and support the use of needed HIV, STI, and HCV prevention and care services among GBMSM and transgender women; and developing priorities and recommendations to improve their health that will be disseminated to inform public health practice, research, and policy. By integrating peer navigation and mHealth strategies, the proposed study provides a unique opportunity to improve health among vulnerable, hidden, and neglected populations living in rural Appalachia. Findings from this research may inform strategies and approaches to address other health disparities in other rural populations.

Interventions

BEHAVIORALPeer Navigation

First, as health advisors, community health leaders will raise awareness of HIV, STIs, and HCV and local prevention and care services and help social network members access services. Thus, the community health leader will describe to the process for HCV testing, and how providers are required to maintain confidentiality. As opinion leaders, community health leaders will reframe health-compromising and bolster health-promoting norms and expectations about testing and use of other prevention and care services. Each community health leader will also conduct formal in-person group activities with their social network members. Our partnership decided that each community health leader will also hold at least 4 formal group sessions during the 12 months of intervention

BEHAVIORALmHealth

In addition to in-person individual and group activities, community health leaders will use mHealth platforms preferred by each social network member (i.e., Facebook , Instagram, testing, and/or GPS-based mobile apps) to communicate with them during the intervention. They will use social media to plan activities and to support use of needed prevention and care services. For example, when planning a group activity (described above), the community health leader will use social media to remind social network members about the activity and help them problem solve barriers to attending. A community health leader and social network member may also communicate "in-real-time" via social media about the process of participating in a syringe services program or accessing PrEP.

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER
National Institute of Nursing Research (NINR)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* reside in one of the rural Appalachian catchment countiesreside in one of the rural Appalachian catchment counties * be ≥18 years of age * report being assigned male sex at birth and having had sex with at least 1 man in past 12 months * provide informed consent

Design outcomes

Primary

MeasureTime frame
Number of participants who have Human Immunodeficiency Virus (HIV) testingbaseline
Number of participants who have Sexually Transmitted Infection (STI) testingbaseline
Number of participants who have Hepatitis C Virus (HCV) testingbaseline
Number of participants who have HIV testingimmediate post-intervention (12 months post-baseline)
Number of participants who have STI testingimmediate post-intervention (12 months post-baseline)
Number of participants who have HCV testingimmediate post-intervention (12 months post-baseline)

Secondary

MeasureTime frameDescription
Number of participants who use prevention--Pre-exposure prophylaxis (PrEP)baseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline).
Number of participants who use prevention--syringe servicesbaseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline).
Number of participants who use HIV care servicesbaseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline).Measured through self-report and medical chart abstraction
Number of participants who use STI treatment servicesbaseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline).Measured through self-report and medical chart abstraction
Number of participants who use HCV treatment servicesbaseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline).Measured through self-report and medical chart abstraction
Number of participants who use gender-affirming care servicesbaseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline).Measured through self-report and medical chart abstraction

Countries

United States

Contacts

CONTACTScott D. Rhodes, Ph.D, MPH
srhodes@wakehealth.edu336-713-5080
PRINCIPAL_INVESTIGATORScott D. Rhodes, Ph.D, MPH

Wake Forest University Health Sciences

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026